Statins and cancer prevention

By M. Demierre, P. Higgins, Stephen B. Gruber, E. Hawk, S. Lippman. Nature Reviews. Cancer, 2005

813 citations recorded by the source corpus.

Subfields: Cancer Research, Pharmacology, Surgery

View Paper: https://www.semanticscholar.org/paper/834e2d02da7257df198002addf72a3924d65fbd0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. A. Albini
2. M. Sporn

Citations in the corpus

• The tumour microenvironment as a target for chemoprevention (2007, background): “Statins reduce cancer incidence, and it has been suggested that possible mechanisms for this effect involve the suppression of inflammation and angiogenesis in the microenvironmen”
• Efalizumab binding to the LFA-1 αL I domain blocks ICAM-1 binding via steric hindrance (2009, background): “Thus, it has become a therapeutic target for the treatment of multiple autoimmune and inflammatory diseases and cancers (8, 26, 27).”
• Statin use and reduced cancer-related mortality. (2012, neutral): “Any 5,620 (30) 31,986 (12) 4,306 (28) 13,304 (29)”